The National Stem Cell Foundation is a 501(c)3 non-profit organization that funds adult stem cell and regenerative medicine research, connects children with limited resources to clinical trials for rare diseases and underwrites the National STEM Scholar Program for middle school science teachers inspiring the next generation of STEM pioneers nationwide.
Paula P. Grisanti, D.M.D. , CEO
John M. Cranor III
Michael J. Grisanti, Secretary
C. Dennis Riggs, Treasurer
Bruce S. Wolff, Chairman
D. Walter Cohen, D.D.S. , Chairman Emeritus
Research: Formerly named the National Foundation to Support Cell Transplant Research, NFCTR became the National Stem Cell Foundation in late 2011 to support peer-reviewed research and clinical trial collaborations in the field of adult stem cell therapies and regenerative medicine to expedite stem cell science. Millions of people, many of them children or young adults, may benefit from stem cell therapies being tested in the clinic now.
We also believe the application of adult stem cell therapies will significantly reduce global healthcare costs. Our four areas of research focus include: Neurodegenerative Disease, Autoimmune Disease, Rare Childhood Disorders, Regenerative Repair.
Education: We fund competitive scholarships for ten middle school science teachers each year as part of the prestigious National STEM Scholar Program, a unique professional development and networking program to provide advanced training for the teachers of aspiring middle school scientists nationwide. By “training the trainers,” the program seeks to inspire the next generation of STEM (Science, Technology, Engineering and Math) innovators and pioneers.
Advocacy: Our patient advocacy programs connect people to life-saving treatments and potential cures.
We fund the national efforts of Sharing America’s Marrow (S.A.M.) to significantly increase the donor pool for life-saving bone marrow transplants. In 2015 and 2016, The S.A.M. team enrolled 24,000 new donors on the National Marrow Donor Program registry and found nearly 400 matches for people on a waiting list. In 2017, they received the RARE Champion of Hope Advocacy Award from Global Genes
In partnership with Duke University’s Pediatric Blood and Marrow Transplant (PBMT) Program, we have established a fund to supplement gap funding for children of limited means participating in clinical trials for rare diseases. NSCF funding focuses on a remaining shortfall, consisting of deductibles and copayments, that health benefit plans require the PBMT Program to collect incident to clinical trials. Working in collaboration with Duke and the affected private and public health benefit plans, NSCF anticipates that its funding will increase the participation by these children in PBMT’s cutting edge and life-saving clinical innovations.